endologix

Sean Lavin of BTIG upgraded shares of Endologix (NASDAQ: ELGX) to Buy. What's notable about the upgrade is that just a few weeks ago on July 7 shares were downgraded to Neutral from Buy. Lavin's decision to return to a Buy rating follows a visit to the company's head office. The analyst notes...

Oppenheimer is raising its PT on shares of Endologix Inc. (NASDAQ: ELGX) from $10 to $11. Endologix closed Wednesday at $8.30.

Oppenheimer has reiterated an Outperform Rating for Endologix Inc (NASDAQ: ELGX) after attending management meetings. According to Oppenheimer, "After spending time with ELGX management on the road this week, we remain convinced that ELGX has the best product pipeline in AAA and that the new...

Oppenheimer has initiated coverage on Endologix, Inc. (NASDAQ: ELGX) with an Outperform rating.